Bond GlaxoSmithKline Capital PLC 0.534% ( US377373AL97 ) in USD

Issuer GlaxoSmithKline Capital PLC
Market price 100.25 %  ▲ 
Country  United Kingdom
ISIN code  US377373AL97 ( in USD )
Interest rate 0.534% per year ( payment 2 times a year)
Maturity 30/09/2023 - Bond has expired



Prospectus brochure in PDF format

Minimal amount 2 000 USD
Total amount 1 250 000 000 USD
Cusip 377373AL9
Standard & Poor's ( S&P ) rating A ( Upper medium grade - Investment-grade )
Moody's rating A2 ( Upper medium grade - Investment-grade )
Detailed description GlaxoSmithKline Capital PLC is a UK-based venture capital firm focused on life sciences investments, primarily supporting early-stage and growth-stage companies developing innovative therapies and technologies within GlaxoSmithKline's strategic areas of interest.

GlaxoSmithKline Capital PLC's USD 1,250,000,000 0.534% bond (ISIN: US377373AL97, CUSIP: 377373AL9), issued in the United Kingdom, matured on September 30, 2023, with a final price of 100%, minimum purchase of 2000, and a semi-annual coupon payment, rated A by S&P and A2 by Moody's.
DateClean price
07/08/2024100.00%
18/09/202399.84%
25/08/202398.46%
02/08/202399.17%
10/07/202397.84%
16/06/202397.55%
24/05/202398.00%
30/04/202396.98%
09/04/202396.72%
22/03/202396.49%
28/02/202396.93%
05/02/202396.18%
16/01/202396.95%
25/12/202295.74%
03/12/202295.47%
11/11/202295.35%
22/10/202294.93%
03/10/202296.17%
16/09/202296.32%
31/08/202296.76%
15/08/202296.98%
31/07/202297.20%
16/07/202296.84%
01/07/202296.95%
16/06/202296.23%
02/06/202297.30%
17/05/202297.04%
02/05/202296.80%
16/04/202297.11%
31/03/202297.24%
16/03/202297.48%
01/03/202298.58%
12/02/202298.18%
27/01/202298.66%
07/01/202299.28%
22/12/202199.47%
05/12/202199.56%
19/11/202199.79%
05/11/202199.91%
22/10/202199.90%
08/10/202199.58%
23/09/2021100.16%
05/09/2021100.20%
22/08/2021100.20%
10/08/2021100.16%
29/07/2021100.25%
17/07/2021100.19%
03/07/2021100.19%
19/06/2021100.17%
03/06/2021100.33%
16/05/2021100.36%
27/04/2021100.25%